Skip to content
HowShorted

Immunic, Inc. short interest in 2021

In 2021, Immunic, Inc.'s disclosed short interest ran from 3.28% of shares outstanding on 15 Jan 2021 to 5.17% on 31 Dec 2021, a change of +1.89 percentage points. The year's high was 7.98% on 15 Jul 2021 and its low 3.28% on 15 Jan 2021, averaging 5.22% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 17.55 days on 28 May 2021. Full history: Immunic, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Immunic, Inc. in 2021

2021 in figures

Start of year
3.28% (15 Jan 2021)
End of year
5.17% (31 Dec 2021)
Change
+1.89 pp
High
7.98% (15 Jul 2021)
Low
3.28% (15 Jan 2021)
Average
5.22%
Highest days to cover
17.55 (28 May 2021)
SEC filings marked
8

Every report in 2021

Immunic, Inc. short interest in 2021
SettlementShort interestDays to coverFilings since previous
15 Jan 20213.28%4.54
29 Jan 20214.55%5.91
12 Feb 20214.33%4.76
26 Feb 20216.34%2.4210-K filed, results (8-K)
15 Mar 20214.50%4.99
31 Mar 20216.85%8.21
15 Apr 20217.01%14.89
30 Apr 20217.16%12.61
14 May 20216.86%9.8110-Q filed, results (8-K)
28 May 20216.82%17.55
15 Jun 20216.68%15.81
30 Jun 20217.13%5.51
15 Jul 20217.98%4.53
30 Jul 20216.24%5.92
13 Aug 20215.40%6.1010-Q filed, results (8-K)
31 Aug 20213.67%6.24
15 Sep 20213.54%9.74
30 Sep 20213.66%7.04
15 Oct 20213.31%1.72
29 Oct 20213.45%5.96
15 Nov 20213.66%8.3610-Q filed, results (8-K)
30 Nov 20213.73%4.93
15 Dec 20214.02%5.84
31 Dec 20215.17%8.84

See also: Immunic, Inc.'s full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.